136 related articles for article (PubMed ID: 32671780)
1. Autophagy and Myeloma.
Zheng Z; Wang L; Cheng S; Wang Y; Zhao W
Adv Exp Med Biol; 2020; 1207():625-631. PubMed ID: 32671780
[TBL] [Abstract][Full Text] [Related]
2. Targeting autophagy in multiple myeloma.
Yun Z; Zhichao J; Hao Y; Ou J; Ran Y; Wen D; Qun S
Leuk Res; 2017 Aug; 59():97-104. PubMed ID: 28599191
[TBL] [Abstract][Full Text] [Related]
3. The Proteasome Inhibitor Bortezomib Maintains Osteocyte Viability in Multiple Myeloma Patients by Reducing Both Apoptosis and Autophagy: A New Function for Proteasome Inhibitors.
Toscani D; Palumbo C; Dalla Palma B; Ferretti M; Bolzoni M; Marchica V; Sena P; Martella E; Mancini C; Ferri V; Costa F; Accardi F; Craviotto L; Aversa F; Giuliani N
J Bone Miner Res; 2016 Apr; 31(4):815-27. PubMed ID: 26551485
[TBL] [Abstract][Full Text] [Related]
4. A plastic SQSTM1/p62-dependent autophagic reserve maintains proteostasis and determines proteasome inhibitor susceptibility in multiple myeloma cells.
Milan E; Perini T; Resnati M; Orfanelli U; Oliva L; Raimondi A; Cascio P; Bachi A; Marcatti M; Ciceri F; Cenci S
Autophagy; 2015; 11(7):1161-78. PubMed ID: 26043024
[TBL] [Abstract][Full Text] [Related]
5. Mechanisms for autophagy modulation by isoprenoid biosynthetic pathway inhibitors in multiple myeloma cells.
Dykstra KM; Allen C; Born EJ; Tong H; Holstein SA
Oncotarget; 2015 Dec; 6(39):41535-49. PubMed ID: 26595805
[TBL] [Abstract][Full Text] [Related]
6. Control of autophagic cell death by caspase-10 in multiple myeloma.
Lamy L; Ngo VN; Emre NC; Shaffer AL; Yang Y; Tian E; Nair V; Kruhlak MJ; Zingone A; Landgren O; Staudt LM
Cancer Cell; 2013 Apr; 23(4):435-49. PubMed ID: 23541952
[TBL] [Abstract][Full Text] [Related]
7. Intracellular NAD(+) depletion induces autophagic death in multiple myeloma cells.
Cea M; Cagnetta A; Patrone F; Nencioni A; Gobbi M; Anderson KC
Autophagy; 2013 Mar; 9(3):410-2. PubMed ID: 23221771
[TBL] [Abstract][Full Text] [Related]
8. Iron chelators induce autophagic cell death in multiple myeloma cells.
Pullarkat V; Meng Z; Donohue C; Yamamoto VN; Tomassetti S; Bhatia R; Krishnan A; Forman SJ; Synold TW
Leuk Res; 2014 Aug; 38(8):988-96. PubMed ID: 24998390
[TBL] [Abstract][Full Text] [Related]
9. Resveratrol inhibits myeloma cell growth, prevents osteoclast formation, and promotes osteoblast differentiation.
Boissy P; Andersen TL; Abdallah BM; Kassem M; Plesner T; Delaissé JM
Cancer Res; 2005 Nov; 65(21):9943-52. PubMed ID: 16267019
[TBL] [Abstract][Full Text] [Related]
10. [The influence of induced autophagy in vitro on proliferation of multiple myeloma cells].
Gao LS; Zhang XH; Zhang H; Zhang YY; Chen L; Fu JX
Zhonghua Xue Ye Xue Za Zhi; 2012 Nov; 33(11):932-7. PubMed ID: 23363751
[TBL] [Abstract][Full Text] [Related]
11. KLF4-SQSTM1/p62-associated prosurvival autophagy contributes to carfilzomib resistance in multiple myeloma models.
Riz I; Hawley TS; Hawley RG
Oncotarget; 2015 Jun; 6(17):14814-31. PubMed ID: 26109433
[TBL] [Abstract][Full Text] [Related]
12. Autophagy induced by FTY720 promotes apoptosis in U266 cells.
Liao A; Hu R; Zhao Q; Li J; Li Y; Yao K; Zhang R; Wang H; Yang W; Liu Z
Eur J Pharm Sci; 2012 Apr; 45(5):600-5. PubMed ID: 22281442
[TBL] [Abstract][Full Text] [Related]
13. Antiestrogen-binding site ligands induce autophagy in myeloma cells that proceeds through alteration of cholesterol metabolism.
Sola B; Poirot M; de Medina P; Bustany S; Marsaud V; Silvente-Poirot S; Renoir JM
Oncotarget; 2013 Jun; 4(6):911-22. PubMed ID: 23978789
[TBL] [Abstract][Full Text] [Related]
14. Knockdown of DEPTOR induces apoptosis, increases chemosensitivity to doxorubicin and suppresses autophagy in RPMI-8226 human multiple myeloma cells in vitro.
Zhang H; Chen J; Zeng Z; Que W; Zhou L
Int J Mol Med; 2013 May; 31(5):1127-34. PubMed ID: 23503641
[TBL] [Abstract][Full Text] [Related]
15. Targeting glucose consumption and autophagy in myeloma with the novel nucleoside analogue 8-aminoadenosine.
Shanmugam M; McBrayer SK; Qian J; Raikoff K; Avram MJ; Singhal S; Gandhi V; Schumacker PT; Krett NL; Rosen ST
J Biol Chem; 2009 Sep; 284(39):26816-30. PubMed ID: 19648108
[TBL] [Abstract][Full Text] [Related]
16. Double autophagy stimulation using chemotherapy and mTOR inhibition combined with hydroxychloroquine for autophagy modulation in patients with relapsed or refractory multiple myeloma.
Scott EC; Maziarz RT; Spurgeon SE; Medvedova E; Gajewski J; Reasor-Heard S; Park B; Kratz A; Thomas GV; Loriaux M; Cascio M; Podolak J; Gordon M; Botelho J; Stadtmauer E; Amaravadi R; Vogl DT
Haematologica; 2017 Jul; 102(7):e261-e265. PubMed ID: 28385778
[No Abstract] [Full Text] [Related]
17. FAM46C and FNDC3A Are Multiple Myeloma Tumor Suppressors That Act in Concert to Impair Clearing of Protein Aggregates and Autophagy.
Manfrini N; Mancino M; Miluzio A; Oliveto S; Balestra M; Calamita P; Alfieri R; Rossi RL; Sassoè-Pognetto M; Salio C; Cuomo A; Bonaldi T; Manfredi M; Marengo E; Ranzato E; Martinotti S; Cittaro D; Tonon G; Biffo S
Cancer Res; 2020 Nov; 80(21):4693-4706. PubMed ID: 32963011
[TBL] [Abstract][Full Text] [Related]
18. Mature adipocytes in bone marrow protect myeloma cells against chemotherapy through autophagy activation.
Liu Z; Xu J; He J; Liu H; Lin P; Wan X; Navone NM; Tong Q; Kwak LW; Orlowski RZ; Yang J
Oncotarget; 2015 Oct; 6(33):34329-41. PubMed ID: 26455377
[TBL] [Abstract][Full Text] [Related]
19. Stew in its Own Juice: Protein Homeostasis Machinery Inhibition Reduces Cell Viability in Multiple Myeloma Cell Lines.
de Oliveira MB; Sanson LFG; Eugenio AIP; Barbosa-Dantas RSS; Colleoni GWB
Curr Mol Med; 2019; 19(2):112-119. PubMed ID: 30834832
[TBL] [Abstract][Full Text] [Related]
20. Polymorphisms within Autophagy-Related Genes as Susceptibility Biomarkers for Multiple Myeloma: A Meta-Analysis of Three Large Cohorts and Functional Characterization.
Clavero E; Sanchez-Maldonado JM; Macauda A; Ter Horst R; Sampaio-Marques B; Jurczyszyn A; Clay-Gilmour A; Stein A; Hildebrandt MAT; Weinhold N; Buda G; García-Sanz R; Tomczak W; Vogel U; Jerez A; Zawirska D; Wątek M; Hofmann JN; Landi S; Spinelli JJ; Butrym A; Kumar A; Martínez-López J; Galimberti S; Sarasquete ME; Subocz E; Iskierka-Jażdżewska E; Giles GG; Rybicka-Ramos M; Kruszewski M; Abildgaard N; Verdejo FG; Sánchez Rovira P; da Silva Filho MI; Kadar K; Razny M; Cozen W; Pelosini M; Jurado M; Bhatti P; Dudzinski M; Druzd-Sitek A; Orciuolo E; Li Y; Norman AD; Zaucha JM; Reis RM; Markiewicz M; Rodríguez Sevilla JJ; Andersen V; Jamroziak K; Hemminki K; Berndt SI; Rajkumar V; Mazur G; Kumar SK; Ludovico P; Nagler A; Chanock SJ; Dumontet C; Machiela MJ; Varkonyi J; Camp NJ; Ziv E; Vangsted AJ; Brown EE; Campa D; Vachon CM; Netea MG; Canzian F; Försti A; Sainz J
Int J Mol Sci; 2023 May; 24(10):. PubMed ID: 37239846
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
